Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer.

Forastiere AA, Zhang Q, Weber RS, Maor MH, Goepfert H, Pajak TF, Morrison W, Glisson B, Trotti A, Ridge JA, Thorstad W, Wagner H, Ensley JF, Cooper JS.

J Clin Oncol. 2013 Mar 1;31(7):845-52. doi: 10.1200/JCO.2012.43.6097. Epub 2012 Nov 26.

2.

Long-term Results of a Multicenter Randomized Phase III Trial of Induction Chemotherapy With Cisplatin, 5-fluorouracil, ± Docetaxel for Larynx Preservation.

Janoray G, Pointreau Y, Garaud P, Chapet S, Alfonsi M, Sire C, Jadaud E, Calais G.

J Natl Cancer Inst. 2015 Dec 16;108(4). pii: djv368. doi: 10.1093/jnci/djv368. Print 2016 Apr.

PMID:
26681800
3.

Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation.

Posner MR, Norris CM, Wirth LJ, Shin DM, Cullen KJ, Winquist EW, Blajman CR, Mickiewicz EA, Frenette GP, Plinar LF, Cohen RB, Steinbrenner LM, Freue JM, Gorbunova VA, Tjulandin SA, Raez LE, Adkins DR, Tishler RB, Roessner MR, Haddad RI; TAX 324 Study Group.

Ann Oncol. 2009 May;20(5):921-7. doi: 10.1093/annonc/mdn752. Epub 2009 Jan 29.

PMID:
19179556
4.

Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy.

Lefebvre JL, Rolland F, Tesselaar M, Bardet E, Leemans CR, Geoffrois L, Hupperets P, Barzan L, de Raucourt D, Chevalier D, Licitra L, Lunghi F, Stupp R, Lacombe D, Bogaerts J, Horiot JC, Bernier J, Vermorken JB; EORTC Head and Neck Cancer Cooperative Group; EORTC Radiation Oncology Group.

J Natl Cancer Inst. 2009 Feb 4;101(3):142-52. doi: 10.1093/jnci/djn460. Epub 2009 Jan 27.

5.

Organ preservation and treatment toxicity with induction chemotherapy followed by radiation therapy or chemoradiation for advanced laryngeal cancer.

Guadagnolo BA, Haddad RI, Posner MR, Weeks L, Wirth LJ, Norris CM, Sullivan CA, Goguen L, Busse PM, Tishler R.

Am J Clin Oncol. 2005 Aug;28(4):371-8.

PMID:
16062079
6.

Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group Phase 2 Study.

Mesía R, Garcia-Saenz JA, Lozano A, Pastor M, Grau JJ, Martínez-Trufero J, Lambeaz J, Martínez-Galán J, Mel JR, González B, Vázquez S, Mañós M, Taberna M, Cirauqui B, Del Barco E, Casado E, Rubió-Casadevall J, Rodríguez-Jaráiz A, Cruz JJ; Spanish Head And Neck Cancer Cooperative Group (Study TTCC-2007/02).

Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):473-480. doi: 10.1016/j.ijrobp.2016.11.016. Epub 2016 Nov 17.

PMID:
28011050
7.

Phase II trial of chemoradiation for organ preservation in resectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: results of Eastern Cooperative Oncology Group Study E2399.

Cmelak AJ, Li S, Goldwasser MA, Murphy B, Cannon M, Pinto H, Rosenthal DI, Gillison M, Forastiere AA.

J Clin Oncol. 2007 Sep 1;25(25):3971-7.

PMID:
17761982
8.

Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: the TREMPLIN randomized phase II study.

Lefebvre JL, Pointreau Y, Rolland F, Alfonsi M, Baudoux A, Sire C, de Raucourt D, Malard O, Degardin M, Tuchais C, Blot E, Rives M, Reyt E, Tourani JM, Geoffrois L, Peyrade F, Guichard F, Chevalier D, Babin E, Lang P, Janot F, Calais G, Garaud P, Bardet E.

J Clin Oncol. 2013 Mar 1;31(7):853-9. doi: 10.1200/JCO.2012.42.3988. Epub 2013 Jan 22. Erratum in: J Clin Oncol. 2013 May 1;31(13):1702.

PMID:
23341517
9.

[Results of definitive radiotherapy for squamous cell carcinomas of the larynx patients with subglottic extension].

Lévy A, Blanchard P, Janot F, Temam S, Bourhis J, Daly-Schveitzer N, Tao Y.

Cancer Radiother. 2014 Jan;18(1):1-6. doi: 10.1016/j.canrad.2013.06.047. Epub 2013 Dec 3. French.

PMID:
24309002
10.

Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer.

Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, Glisson B, Trotti A, Ridge JA, Chao C, Peters G, Lee DJ, Leaf A, Ensley J, Cooper J.

N Engl J Med. 2003 Nov 27;349(22):2091-8.

11.

Treatment results and prognostic factors of advanced T3--4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience.

Nguyen-Tan PF, Le QT, Quivey JM, Singer M, Terris DJ, Goffinet DR, Fu KK.

Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1172-80.

PMID:
11483326
12.

Larynx preservation using induction chemotherapy plus radiation therapy as an alternative to laryngectomy in advanced head and neck cancer. A long-term follow-up report.

Karp DD, Vaughan CW, Carter R, Willett B, Heeren T, Calarese P, Zeitels S, Strong MS, Hong WK.

Am J Clin Oncol. 1991 Aug;14(4):273-9.

PMID:
1713738
13.

Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm.

Urba S, Wolf G, Eisbruch A, Worden F, Lee J, Bradford C, Teknos T, Chepeha D, Prince M, Hogikyan N, Taylor J.

J Clin Oncol. 2006 Feb 1;24(4):593-8. Epub 2005 Dec 27.

PMID:
16380415
14.

Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer.

Fung K, Lyden TH, Lee J, Urba SG, Worden F, Eisbruch A, Tsien C, Bradford CR, Chepeha DB, Hogikyan ND, Prince ME, Teknos TN, Wolf GT.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1395-9. Epub 2005 Aug 8.

PMID:
16087298
15.

Does induction chemotherapy still have a role in larynx preservation strategies? The experience of Institut Catala d'Oncologia in stage III larynx carcinoma.

Majem M, Mesia R, Mañós M, Gomez J, Galiana R, Cardenal F, Juan A, Montes A, Perez FJ, Nogues J, Llluch JR.

Laryngoscope. 2006 Sep;116(9):1651-6.

PMID:
16954998
17.

Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation.

Pointreau Y, Garaud P, Chapet S, Sire C, Tuchais C, Tortochaux J, Faivre S, Guerrif S, Alfonsi M, Calais G.

J Natl Cancer Inst. 2009 Apr 1;101(7):498-506. doi: 10.1093/jnci/djp007. Epub 2009 Mar 24.

PMID:
19318632
18.

Selection of therapeutic treatment with alternating chemoradiotherapy for larynx preservation in laryngeal carcinoma patients.

Ijichi K, Hanai N, Kawakita D, Ozawa T, Suzuki H, Hirakawa H, Kodaira T, Murakami S, Hasegawa Y.

Jpn J Clin Oncol. 2014 Nov;44(11):1063-9. doi: 10.1093/jjco/hyu131. Epub 2014 Sep 3.

PMID:
25187666
19.

Laryngeal preservation by induction chemotherapy plus radiotherapy in locally advanced head and neck cancer: the M. D. Anderson Cancer Center experience.

Shirinian MH, Weber RS, Lippman SM, Dimery IW, Earley CL, Garden AS, Michaelson J, Morrison WH, Kramer A, Byers R, et al.

Head Neck. 1994 Jan-Feb;16(1):39-44.

PMID:
7510276
20.

Long-term follow-up and salvage surgery in patients with T2N0M0 squamous cell carcinoma of the glottic larynx following concurrent chemoradiation therapy with cisplatin and 5-fluorouracil for laryngeal preservation.

Furusaka T, Susaki Y, Saito T, Katsura Y, Ikeda M.

Acta Otolaryngol. 2013 Jan;133(1):91-8. doi: 10.3109/00016489.2012.715372. Epub 2012 Oct 29.

PMID:
23106387

Supplemental Content

Support Center